Current Gastroenterology Reports

, Volume 4, Issue 4, pp 302–307

New perspectives on hepatitis E

  • Kenneth C. Hyams
Article

Abstract

The infectious agent causing epidemic non-A, non-B hepatitis was identified in 1983 from a human challenge experiment. The novel hepatitis E virus (HEV) subsequently was cloned in 1990 and the genome sequenced. HEV transmission is highly endemic in Asia, the Middle East, and Africa. Fecal contamination of drinking water is the most common mode of spread. Although usually asymptomatic, HEV infection can cause fulminant hepatitis. Recent studies indicate that hepatitis E may be a zoonotic disease, with pigs and possibly rats serving as reservoirs for human infection. A recombinant HEV vaccine is currently in phase III clinical trials. The characterization of the major types of viral hepatitis during the last 20 years illustrates how modern genetic technology has revolutionized research in infectious diseases. Within less than two decades of the discovery of HEV, its epidemiology has been described, serologic tests have been developed, and a candidate vaccine has been evaluated in clinical trials.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References and Recommended Reading

  1. 1.
    Purcell RH, Alter HJ, Dienstag JL: Non-A, non-B hepatitis. Yale J Biol Med 1976, 49:243–250. This important article reveals how far we have come in our understanding of viral hepatitis — particularly non-A, non-B hepatitis — in just the last 25 years. Very little was known about non-A, non-B hepatitis in 1976, including whether it was caused by just one virus or by multiple infectious agents.PubMedGoogle Scholar
  2. 2.
    Aggarwal R, Krawczynski K: Hepatitis E: an overview and recent advances in clinical and laboratory research. J Gastroenterol Hepatol 2000, 15:9–20.PubMedCrossRefGoogle Scholar
  3. 3.
    Khuroo MS: Study of an epidemic of non-A, non-B hepatitis: possibility of another human hepatitis virus distinct from posttransfusion non-A, non-B type. Am J Med 1980, 68:818–824.PubMedCrossRefGoogle Scholar
  4. 4.
    Wong DC, Purcell RH, Sreenivasan MA, et al.: Epidemic and endemic hepatitis in India: evidence for non-A, non-B hepatitis virus aetiology. Lancet 1980, 2:876–878.PubMedCrossRefGoogle Scholar
  5. 5.
    Kane MA, Bradley DW, Shrestha SM, et al.: Epidemic non-A, non-B hepatitis in Nepal: recovery of a possible etiologic agent and transmission studies in marmosets. JAMA 1984, 252:3140–3145.PubMedCrossRefGoogle Scholar
  6. 6.
    Balayan MS, Andjaparidze AG, Savinskaya SS, et al.: Evidence for a virus in non-A, non-B hepatitis transmitted via the fecal-oral route. Intervirology 1983, 20:23–31. This paper reports on one of the most important studies in HEV research. The authors demonstrated conclusively that a unique virus, distinct from HAV, caused enterically transmitted viral hepatitis. The study also led to a crude serologic test for HEV infection. Although this study was conducted less than two decades ago, it probably could not be repeated now because a volunteer was intentionally infected with a potentially fatal agent. Although the volunteer was one of the study investigators, there is little likelihood that an institutional review board would approve this study today.PubMedCrossRefGoogle Scholar
  7. 7.
    Reyes GR, Purdy MA, Kim JP, Luk KC, et al.: Isolation of a cDNA from the virus responsible for enterically transmitted non-A, non-B hepatitis. Science 1990, 247:1335–1339.PubMedCrossRefGoogle Scholar
  8. 8.
    Tam AW, Smith MM, Guerra ME, et al.: Hepatitis E virus (HEV): molecular cloning and sequencing of the full-length viral genome. Virology 1991, 185:120–131.PubMedCrossRefGoogle Scholar
  9. 9.
    Tsarev SA, Emerson SU, Reyes GR, et al.: Characterization of a prototype strain of hepatitis E virus. Proc Natl Acad Sci U S A 1992, 89:559–563.PubMedCrossRefGoogle Scholar
  10. 10.
    Berke T, Matson DO: Reclassification of the Caliciviridae into distinct genera and exclusion of hepatitis E virus from the family on the basis of comparative phylogenetic analysis. Arch Virol 2000, 145:1421–1436.PubMedCrossRefGoogle Scholar
  11. 11.
    Schlauder GG, Frider B, Sookoian S, et al.: Identification of 2 novel isolates of hepatitis E virus in Argentina. J Infect Dis 2000, 182:294–297.PubMedCrossRefGoogle Scholar
  12. 12.
    Schlauder GG, Mushahwar IK: Genetic heterogeneity of hepatitis E virus. J Med Virol 2001, 65:282–292.PubMedCrossRefGoogle Scholar
  13. 13.
    Purcell RH, Emerson SU: Animal models of hepatitis A and E. ILAR J 2001, 42:161–177.PubMedGoogle Scholar
  14. 14.
    Meng XJ, Purcell RH, Halbur PG, et al.: A novel virus in swine is closely related to the human hepatitis E virus. Proc Natl Acad Sci U S A 1997, 94:9860–9865. This article reports a study confirming that pigs are infected with a virus very similar to human HEV.PubMedCrossRefGoogle Scholar
  15. 15.
    Kabrane-Lazizi Y, Fine JB, Elm J, et al.: Evidence for widespread infection of wild rats with hepatitis E virus in the United States. Am J Trop Med Hyg 1999, 61:331–335.PubMedGoogle Scholar
  16. 16.
    Haqshenas G, Shivaprasad HL, Woolcock PR, et al.: Genetic identification and characterization of a novel virus related to human hepatitis E virus from chickens with hepatitis-splenomegaly syndrome in the United States. J Gen Virol 2001, 82:2449–2462.PubMedGoogle Scholar
  17. 17.
    Schlauder GG, Dawson GJ, Erker JC, et al.: The sequence and phylogenetic analysis of a novel hepatitis E virus isolated from a patient with acute hepatitis reported in the United States. J Gen Virol 1998, 79:447–456. Although only a case report, this study is significant because it clearly indicates that humans may be infected with swine HEV, suggesting that hepatitis E might be a zoonotic disease.PubMedGoogle Scholar
  18. 18.
    Meng XJ, Halbur PG, Shapiro MS, et al.: Genetic and experimental evidence for cross-species infection by swine hepatitis E virus. J Virol 1998, 72:9714–9721.PubMedGoogle Scholar
  19. 19.
    Meng XJ, Halbur PG, Haynes JS, et al.: Experimental infection of pigs with the newly identified swine hepatitis E virus (swine HEV), but not with human strains of HEV. Arch Virol 1998, 143:1405–1415.PubMedCrossRefGoogle Scholar
  20. 20.
    Meng XJ: Novel strains of hepatitis E virus identified from humans and other animal species: is hepatitis E a zoonosis? J Hepatol 2000, 33:842–845.PubMedCrossRefGoogle Scholar
  21. 21.
    Centers for Disease Control: Enterically transmitted non-A, non-B hepatitis — Mexico. MMWR Morb Mortal Wkly Rep 1987, 36:597–602.Google Scholar
  22. 22.
    Meng H: A food-borne outbreak of non-A non-B hepatitis. Zhonghua Yu Fang Yi Xue Za Zhi 1987, 21:28–30.PubMedGoogle Scholar
  23. 23.
    Aggarwal R, Naik SR: Hepatitis E: Intrafamilial transmission versus waterborne spread. J Hepatol 1994, 21:718–723.PubMedCrossRefGoogle Scholar
  24. 24.
    Khuroo MS, Kamili S, Jameel S: Vertical transmission of hepatitis E virus. Lancet 1995, 345:1025–1026.PubMedCrossRefGoogle Scholar
  25. 25.
    Psichogiou M, Tzala E, Boletis J, et al.: Hepatitis E virus infection in individuals at high risk of transmission of non-A, non-B hepatitis and sexually transmitted diseases. Scand J Infect Dis 1996, 28:443–445.PubMedGoogle Scholar
  26. 26.
    Barzilai A, Schulman S, Karetnyi YV, et al.: Hepatitis E virus infection in hemophiliacs. J Med Virol 1995, 46:153–156.PubMedCrossRefGoogle Scholar
  27. 27.
    Bile K, Isse A, Mohamud O, et al.: Contrasting roles of rivers and wells as sources of drinking water on attack and fatality rates in a hepatitis E epidemic in Somalia. Am J Trop Med Hyg 1994, 51:466–474.PubMedGoogle Scholar
  28. 28.
    Corwin AL, Tien NTK, Bounlu K, et al.: The unique riverine ecology of hepatitis E virus transmission in Southeast Asia. Trans R Soc Trop Med Hyg 1999, 93:255–260.PubMedCrossRefGoogle Scholar
  29. 29.
    Corwin AL, Khiem HB, Clayson ET, et al.: A waterborne outbreak of hepatitis E virus transmission in Southwestern Vietnam. Am J Trop Med Hyg 1996, 54:559–562.PubMedGoogle Scholar
  30. 30.
    Corwin A, Jarot K, Lubis I, et al.: Two years‘ investigation of epidemic hepatitis E virus transmission in West Kalimantan (Borneo), Indonesia. Trans R Soc Trop Med Hyg 1995, 89:262–265.PubMedCrossRefGoogle Scholar
  31. 31.
    Tsega E, Hansson B-G, Krawczynski K, Nordenfelt E: Acute sporadic viral hepatitis in Ethiopia: causes, risk factors, and effects on pregnancy. Clin Infect Dis 1992, 14:961–965.PubMedGoogle Scholar
  32. 32.
    Hyams KC, McCarthy MC, Kaur M, et al.: Acute sporadic hepatitis E in children living in Cairo Egypt. J Med Virol 1992, 37:274–277.PubMedCrossRefGoogle Scholar
  33. 33.
    Piper-Jenks N, Horowitz HW, Schwartz E: Risk of hepatitis E infection to travelers. J Travel Med 2000, 7:194–199. This article provides an excellent overview of the epidemiology of hepatitis E and the risk of infection for travelers.PubMedCrossRefGoogle Scholar
  34. 34.
    Fix AD, Abdel-Hamid M, Purcell RH, et al.: Prevalence of antibodies to hepatitis E in two rural Egyptian communities. Am J Trop Med Hyg 2000, 62:519–523.PubMedGoogle Scholar
  35. 35.
    Centers for Disease Control: Hepatitis E among U.S. travelers, 1989–1992. MMWR Morb Mortal Wkly Rep 1993, 42:1–4.Google Scholar
  36. 36.
    Mast EE, Kuramoto IK, Favorov MO, et al.: Prevalence of and risk factors for antibody to hepatitis E virus seroreactivity among blood donors in Northern California. J Infect Dis 1997, 176:34–40.PubMedCrossRefGoogle Scholar
  37. 37.
    Skidmore SJ, Sherratt LM: Hepatitis E infection in the UK. J Viral Hepat 1996, 3:103–105.PubMedGoogle Scholar
  38. 38.
    Drobeniuc J, Favorov MO, Shapiro CN, et al.: Hepatitis E virus antibody prevalence among persons who work with swine. J Infect Dis 2001, 184:1594–1597.PubMedCrossRefGoogle Scholar
  39. 39.
    Smalligan RD, Lange WR, Frame JD, et al.: The risk of viral hepatitis A, B, C, and E among North American missionaries. Am J Trop Med Hyg 1995, 53:233–236.PubMedGoogle Scholar
  40. 40.
    Burans JP, Sharp T, Wallace M, et al.: The threat of hepatitis E virus infection in Somalia during Operation Restore Hope. Clin Infect Dis 1994, 18:100–102.PubMedGoogle Scholar
  41. 41.
    Buisson Y, Coursaget P, Bercion R, et al.: Hepatitis E virus infection in soldiers sent to endemic regions. Lancet 1994, 344:1165–1166.PubMedCrossRefGoogle Scholar
  42. 42.
    Alecci A, Bonciani M, Tola T: Prevalence of anti-HEV among Italian soldiers sent in East Africa for Restore Hope‘ mission. Eur J Epidemiol 1997, 13:735.PubMedCrossRefGoogle Scholar
  43. 43.
    Soe S, Uchida T, Suzuki K, et al.: Enterically transmitted non-A, non-B hepatitis in cynomolgus monkeys: morphology and probable mechanism of hepatocellular necrosis. Liver 1989, 9:135–145.PubMedGoogle Scholar
  44. 44.
    Tsarev SA, Tsareva TS, Emerson SU, et al.: Infectivity titration of a prototype strain of hepatitis E virus in cynomolgus monkeys. J Med Virol 1994, 43:135–142.PubMedCrossRefGoogle Scholar
  45. 45.
    Mushahwar IK, Dawson GJ, Bile KM, Magnius LO: Serological studies of an enterically transmitted non-A, non-B hepatitis in Somalia. J Med Virol 1993, 40:218–221.PubMedCrossRefGoogle Scholar
  46. 46.
    Hyams KC, Purdy MA, Kaur M, et al.: Acute sporadic hepatitis E in Sudanese children: analysis based on a new western blot assay. J Infect Dis 1992, 165:1001–1005.PubMedGoogle Scholar
  47. 47.
    Nanda SK, Yalcinkaya K, Panigrahi AK, et al.: Etiological role of hepatitis E virus in sporadic fulminant hepatitis. J Med Virol 1994, 42:133–137.PubMedCrossRefGoogle Scholar
  48. 48.
    Hussaini SH, Skidmore SJ, Richardson P, et al.: Severe hepatitis E infection during pregnancy. J Viral Hepatol 1997, 4:51–54.CrossRefGoogle Scholar
  49. 49.
    Khuroo MS, Kamili S, Dar MY, et al.: Hepatitis E and long-term antibody status. Lancet 1993, 341:1355.PubMedGoogle Scholar
  50. 50.
    Bryan JP, Tsarev SA, Iqbal M, et al.: Epidemic hepatitis E in Pakistan: patterns of serologic response and evidence that antibody to hepatitis E virus protects against disease. J Infect Dis 1994, 170:517–521.PubMedGoogle Scholar
  51. 51.
    Tsarev SA, Tsareva TS, Emerson SU, et al.: Successful passive and active immunization of cynomolgus monkeys against hepatitis E. Proc Natl Acad Sci U S A 1994, 91:10198–10202.PubMedCrossRefGoogle Scholar
  52. 52.
    Pillot J, Turkoglu S, Dubreuil P, et al.: Cross-reactive immunity against different strains of the hepatitis E virus transferable by simian and human sera. C R Acad Sci III 1995, 318:1059–1064.PubMedGoogle Scholar
  53. 53.
    Krawczynski K, Bradley DW: Enterically transmitted non-A, non-B hepatitis: identification of virus-associated antigen in experimentally infected cynomolgus macaques. J Infect Dis 1989, 159:1042–1049.PubMedGoogle Scholar
  54. 54.
    Purdy MA, McCaustland KA, Krawczynski K, et al.: Expression of a hepatitis E virus (HEV)-trpE fusion protein containing epitopes recognized by antibodies in sera from human cases and experimentally infected primates. Arch Virol 1992, 123:335–349.PubMedCrossRefGoogle Scholar
  55. 55.
    He J, Tam AW, Yarbough PO, Reyes GR, Carl M: Expression and diagnostic utility of hepatitis E virus putative structural proteins expressed in insect cells. J Clin Microbiol 1993, 31:2167–2173.PubMedGoogle Scholar
  56. 56.
    Tsarev SA, Tsareva TS, Emerson SU, et al.: ELISA for antibody to hepatitis E virus (HEV) based on complete open-readying frame-2 protein expressed in insect cells: identification of HEV infection in primates. J Infect Dis 1993, 168:369–378.PubMedGoogle Scholar
  57. 57.
    McCaustland KA, Bi S, Purdy MA, Bradley DW: Application of two RNA extraction methods prior to amplification of hepatitis E virus nucleic acid by the polymerase chain reaction. J Virol Methods 1991, 35:331–342.PubMedCrossRefGoogle Scholar
  58. 58.
    Aggarwal R, McCaustland KA: Hepatitis E virus RNA detection in serum and feces specimens with the use of microspin columns. J Virol Methods 1998, 74:209–213.PubMedCrossRefGoogle Scholar
  59. 59.
    Tam AW, White R, Yarbough PO, et al.: In vitro infection and replication of hepatitis E virus in primary cynomolgus macaque hepatocytes. Virology 1997, 238:94–102.PubMedCrossRefGoogle Scholar
  60. 60.
    McCrudden R, O‘Connell S, Farrant T, et al.: Sporadic acute hepatitis E in United Kingdom: an underdiagnosed phenomenon? Gut 2000, 46:732–733.PubMedCrossRefGoogle Scholar
  61. 61.
    Mast EE, Alter MJ, Holland PV, Purcell RH: Evaluation of assays for antibody to hepatitis E virus by a serum panel: Hepatitis E Virus Antibody Serum Panel Evaluation Group. Hepatology 1998, 27:857–861.PubMedCrossRefGoogle Scholar
  62. 62.
    Khuroo MS, Dar MY: Hepatitis E: evidence for person-to-person transmission and inability of low dose immune serum globulin from an Indian source to prevent it. Indian J Gastroenterol 1992, 11:113–116.PubMedGoogle Scholar
  63. 63.
    Stevenson P: Nepal calls the shots in hepatitis E virus vaccine trial. Lancet 2000, 355:1623.PubMedCrossRefGoogle Scholar
  64. 64.
    Arankalle VA, Favorov MO, Chadha MS, et al.: Rhesus monkeys infected with hepatitis E virus (HEV) from the former USSR are immune to subsequent challenge with an Indian strain of HEV. Acta Virol 1993, 37:515–518.PubMedGoogle Scholar
  65. 65.
    Arankalle VA, Chadha MS, Chobe LP, et al.: Cross-challenge studies in Rhesus monkeys employing different Indian isolates of hepatitis E virus. J Med Virol 1995, 46:358–363.PubMedCrossRefGoogle Scholar
  66. 66.
    Arankalle VA, Chadha MS, Chobe LP: Long-term serological follow up and cross-challenge studies in rhesus monkeys experimentally infected with hepatitis E virus. J Hepatol 1999, 30:199–204.PubMedCrossRefGoogle Scholar
  67. 67.
    Emerson SU, Purcell RH: Recombinant vaccines for hepatitis E. Trends Molec Med 2001, 7:462–466. This excellent article should be compared with that of Purcell et al. [1] to understand how far we have come in our understanding of non-A, non-B hepatitis in the last 25 years. Of note, one of the authors of the original paper is still one of the most productive investigators in the field of hepatitis E research.CrossRefGoogle Scholar
  68. 68.
    Meng XJ, Wiseman B, Elvinger F, et al.: Prevalence of antibodies to hepatitis E virus in veterinarians working with swine and in normal blood donors in the United States and other countries. J Clin Microbiol 2002, 40:117–122.PubMedCrossRefGoogle Scholar
  69. 69.
    Purdy MA, McCaustland KA, Krawczynski K, et al.: Preliminary evidence that a trpE-HEV fusion protein protects Cynomolgus macaques against challenge with wild-type hepatitis E virus (HEV). J Med Virol 1993, 41:90–94.PubMedCrossRefGoogle Scholar
  70. 70.
    Tsarev SA, Tsareva TS, Emerson SU, et al.: Recombinant vaccine against hepatitis E: dose response and protection against heterologous challenge. Vaccine 1997, 15:1834–1838. This important study indicates that a hepatitis E vaccine based on the capsid protein would be broadly effective against different strains from different regions. Interestingly, the hepatitis E vaccine was not effective following exposure, unlike the hepatitis A vaccine.PubMedCrossRefGoogle Scholar
  71. 71.
    Zhang M, Emerson SU, Nguyen H, et al.: Immunogenicity and protective efficacy of a vaccine prepared from 53 kDa truncated hepatitis E virus capsid protein expressed in insect cells. Vaccine 2001, 20:853–857.PubMedCrossRefGoogle Scholar
  72. 72.
    Shlim DR, Innis BL: Hepatitis E vaccine for travelers? J Travel Med 2000, 7:167–169.PubMedCrossRefGoogle Scholar

Copyright information

© Current Science Inc 2002

Authors and Affiliations

  • Kenneth C. Hyams
    • 1
  1. 1.Department of Veterans AffairsOffice of Public Health and Environmental HazardsWashingtonUSA

Personalised recommendations